Skip to main content

Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 511–525 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2697
NOTCH3 Mutation Detection (CADASIL) Test

This test detects pathogenic mutations in the NOTCH3 gene associated with CADASIL.

Peripheral Whole Blood (EDTA) 5 Business Days 1,800.00 AED
View
View test specifications and preparation
What it measures
["NOTCH3 gene pathogenic variants", "CADASIL genetic predisposition"]
Parameters
[]
Preparation
["No fasting required", "Continue all prescribed medications"]
Indications
["Suspected CADASIL based on clinical presentation", "Family history of CADASIL", "Recurrent ischemic events in young adults"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94212-5 ICD-10: I67.85
Clinical summary
This test detects pathogenic mutations in the NOTCH3 gene associated with CADASIL.
TEST-3621
NPHP1 Gene (Nephronophthisis Type 1) Genetic Test

This test identifies pathogenic variants in the NPHP1 gene associated with nephronophthisis type 1.

Peripheral whole blood (EDTA), extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DNA sequence variants in the NPHP1 gene", "Copy Number Variations (CNV) in the NPHP1 gene"]
Parameters
[]
Preparation
["Genetic counselling session required before sample collection", "Fasting is not required"]
Indications
["Suspected nephronophthisis type 1", "Family history of nephronophthisis", "Evaluation of childhood kidney disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q61.8
Clinical summary
This test identifies pathogenic variants in the NPHP1 gene associated with nephronophthisis type 1.
TEST-3637
NPHS1 Gene Nephrotic Syndrome Type 2 Genetic Test

This test detects pathogenic variants in the NPHS1 gene associated with congenital nephrotic syndrome of the Finnish type.

Peripheral Whole Blood (EDTA) or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NPHS1 gene", "Copy Number Variations (CNV) in the NPHS1 gene"]
Parameters
[]
Preparation
["No special preparation required", "Mandatory pre-test genetic counselling session"]
Indications
["Suspected congenital nephrotic syndrome of the Finnish type", "Family history of NPHS1-related nephrotic syndrome", "Early-onset nephrotic syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81430-7 ICD-10: N04.9
Clinical summary
This test detects pathogenic variants in the NPHS1 gene associated with congenital nephrotic syndrome of the Finnish type.
TEST-3596
NPHS2 Gene Nephrotic Syndrome Genetic Test

This test analyzes the NPHS2 gene to detect pathogenic variants associated with steroid-resistant nephrotic syndrome (SRNS). It provides a definitive genetic diagnosis for individu...

Whole Blood (EDTA) or Buccal Swab 3–4 Weeks (18–28 days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NPHS2 gene", "Steroid-resistant nephrotic syndrome (SRNS) genetic cause"]
Parameters
[]
Preparation
["No fasting is required", "Routine medications do not affect DNA quality"]
Indications
["Diagnosis of steroid-resistant nephrotic syndrome (SRNS)", "Family screening for NPHS2-related SRNS", "Guiding treatment decisions in SRNS"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21665-8 ICD-10: N04.9
Clinical summary
This test analyzes the NPHS2 gene to detect pathogenic variants associated with steroid-resistant nephrotic syndrome (SRNS). It provides a definitive genetic diagnosis for individuals presenting with SRNS.
TEST-4439
NPPA Gene (Atrial Fibrillation, Familial Type 6) Genetic Test

This genetic test evaluates the NPPA gene for pathogenic variants associated with familial atrial fibrillation type 6.

Peripheral whole blood (3–5 mL in EDTA tube) or buccal swab 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NPPA gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions", "Copy number changes"]
Parameters
[]
Preparation
["No fasting required", "Continue routine medications"]
Indications
["Strong family history of atrial fibrillation", "Atrial fibrillation diagnosed before age 60", "Lone atrial fibrillation of unknown cause", "Suspected genetic etiology for syncope or arrhythmias"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88878-8 ICD-10: I48.0, I48.1, I48.2, Z83.49
Clinical summary
This genetic test evaluates the NPPA gene for pathogenic variants associated with familial atrial fibrillation type 6.
TEST-5973
NR0B1 Gene Adrenal Hypoplasia Genetic Test

This test identifies pathogenic variants in the NR0B1 gene, the primary cause of X-linked adrenal hypoplasia congenita (AHC). It confirms the diagnosis and identifies carriers with...

Whole blood (EDTA tube), FTA card dried blood spot, or previously extracted DNA 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NR0B1 (DAX1) gene", "Copy Number Variants (CNVs) within the NR0B1 gene"]
Parameters
[]
Preparation
["No fasting required.", "No medication changes required.", "Genetic counselling session mandatory before sample collection."]
Indications
["Confirmation of primary adrenal insufficiency", "Identification of carriers in at-risk families", "Guidance for lifelong endocrine management", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21626-2 ICD-10: Q89.1
Clinical summary
This test identifies pathogenic variants in the NR0B1 gene, the primary cause of X-linked adrenal hypoplasia congenita (AHC). It confirms the diagnosis and identifies carriers within families.
TEST-3723
NR1H4 Gene-Related Intrahepatic Cholestasis of Pregnancy (ICP) Test

This genetic test evaluates the NR1H4 gene for pathogenic variants associated with Intrahepatic Cholestasis of Pregnancy (ICP).

Whole blood (EDTA) or Dried Blood Spot (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NR1H4 gene coding region variants", "Pathogenic mutations linked to ICP"]
Parameters
[]
Preparation
["No fasting required", "Detailed family pedigree chart needed", "Pre-genetic counselling session mandatory"]
Indications
["Pregnant women with unexplained pruritus", "Pregnant women with elevated bile acids", "Family history of cholestasis", "Risk assessment for severe ICP"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76386-8 ICD-10: O26.61
Clinical summary
This genetic test evaluates the NR1H4 gene for pathogenic variants associated with Intrahepatic Cholestasis of Pregnancy (ICP).
TEST-2432
NR2E1 Gene Polymicrogyria Bilateral Occipital Genetic Test

This genetic test identifies pathogenic variants in the NR2E1 gene associated with bilateral occipital polymicrogyria (BOP).

Whole Blood (EDTA) or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NR2E1 gene", "Deletions and duplications in the NR2E1 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions"]
Indications
["Diagnosis of bilateral occipital polymicrogyria (BOP)", "Identification of NR2E1 gene variants", "Family planning and recurrence risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94223-0 ICD-10: Q04.8
Clinical summary
This genetic test identifies pathogenic variants in the NR2E1 gene associated with bilateral occipital polymicrogyria (BOP).
TEST-3997
NR3C2 Gene Hypertension Early Onset Genetic Test

This test detects pathogenic variants in the NR3C2 gene associated with early-onset, salt-sensitive hypertension.

Whole Blood / FTA Card / Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the NR3C2 gene", "Mineralocorticoid receptor gene sequence"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions or bone marrow transplants"]
Indications
["Individuals with early-onset hypertension (before age 30)", "Individuals with a family history of early-onset hypertension", "Individuals with salt-sensitive hypertension"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93934-1 ICD-10: I10, Z13.79
Clinical summary
This test detects pathogenic variants in the NR3C2 gene associated with early-onset, salt-sensitive hypertension.
TEST-3563
NR3C2 Gene Pseudohypoaldosteronism Type 1, Autosomal Dominant Genetic Test

This test evaluates the NR3C2 gene for pathogenic variants associated with autosomal dominant pseudohypoaldosteronism type 1 (PHA1). It identifies sequence variants and copy-number...

Whole blood (EDTA), extracted DNA (≥1 µg), or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Sequence variants in the NR3C2 gene", "Copy-number variations (CNVs) in the NR3C2 gene"]
Parameters
[]
Preparation
["No fasting is needed.", "Continue all prescribed medications unless advised otherwise by your doctor.", "A mandatory pre-test genetic counselling session is required."]
Indications
["Suspected diagnosis of autosomal dominant pseudohypoaldosteronism type 1 (PHA1)", "Family history of PHA1", "Differential diagnosis of salt-wasting disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E26.1, Z13.79, Z15.89
Clinical summary
This test evaluates the NR3C2 gene for pathogenic variants associated with autosomal dominant pseudohypoaldosteronism type 1 (PHA1). It identifies sequence variants and copy-number variations (CNVs) within the gene.
TEST-2504
NRAS Gene Noonan Syndrome Type 6 Genetic Test

This genetic test analyzes the NRAS gene to identify mutations associated with Noonan syndrome type 6.

Peripheral whole blood (3–5 mL EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NRAS gene coding region", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Suspected Noonan syndrome type 6 based on clinical features", "Family history of Noonan syndrome", "Need for molecular confirmation for diagnosis and management"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79509-3 ICD-10: Q87.19
Clinical summary
This genetic test analyzes the NRAS gene to identify mutations associated with Noonan syndrome type 6.
TEST-2769
NRG1 Gene Hirschsprung Disease Genetic Test

This test evaluates the NRG1 gene for pathogenic variants associated with Hirschsprung disease.

Whole Blood (EDTA / FTA Card) or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NRG1 gene coding regions", "NRG1 gene intron-exon boundaries"]
Parameters
[]
Preparation
["No fasting required", "Do not discontinue prescribed medications without consulting the referring physician"]
Indications
["Suspected Hirschsprung disease", "Family history of Hirschsprung disease", "Pre-surgical planning for Hirschsprung disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96603-3 ICD-10: Q43.1
Clinical summary
This test evaluates the NRG1 gene for pathogenic variants associated with Hirschsprung disease.
TEST-2759
NRTN Gene Hirschsprung Disease Genetic Test

This test evaluates the NRTN gene for mutations associated with Hirschsprung disease.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 21 to 28 business days (3–4 weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["NRTN gene sequence", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"]
Parameters
[{"name": "Methodology", "reference_range": "Next Generation Sequencing (NGS) – full gene coverage"}, {"name": "Diagnostic Sensitivity", "reference_range": ">99.9%"}]
Preparation
["Inform team of recent blood transfusions (within 7 days)", "Inform team of active infections", "Inform team of medications", "Completed consent form and clinical questionnaire required"]
Indications
["Clinical suspicion of Hirschsprung disease", "Family history of Hirschsprung disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94215-7 ICD-10: Q43.1
Clinical summary
This test evaluates the NRTN gene for mutations associated with Hirschsprung disease.
TEST-3995
NSDHL Gene CK Syndrome Genetic Test

This genetic test evaluates the NSDHL gene for mutations associated with Cockayne Syndrome (CK syndrome). It identifies specific genetic variants that cause the disorder.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["NSDHL gene coding region mutations", "Flanking intronic regions"]
Parameters
[]
Preparation
["No specific fasting required.", "Continue all prescribed medications unless directed otherwise by physician."]
Indications
["Suspected Cockayne Syndrome (CK syndrome)", "Family history of CK syndrome", "Need for recurrence risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81264-3 ICD-10: Q87.89
Clinical summary
This genetic test evaluates the NSDHL gene for mutations associated with Cockayne Syndrome (CK syndrome). It identifies specific genetic variants that cause the disorder.
TEST-5766
NT5C2 Gene SPG45 Genetic Test

This test sequences the entire NT5C2 gene to detect pathogenic variants associated with Hereditary Spastic Paraplegia type 45 (SPG45). It identifies single-nucleotide variants, sma...

Whole Blood (2–5 mL), Saliva, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single-nucleotide variants in NT5C2 gene", "Small insertions/deletions in NT5C2 gene", "Copy number changes in NT5C2 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected diagnosis of Hereditary Spastic Paraplegia type 45 (SPG45)", "Carrier testing for individuals with a family history of SPG45", "Family planning for individuals at risk of carrying SPG45 mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21653-2 ICD-10: G11.4
Clinical summary
This test sequences the entire NT5C2 gene to detect pathogenic variants associated with Hereditary Spastic Paraplegia type 45 (SPG45). It identifies single-nucleotide variants, small insertions/deletions, and copy number changes.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.